$750/pill CEO accused of illegally using assets from former company to pay debts.
Tag: Retrophin
$750/pill pharma company under investigation by Senate for price gouging | Ars Technica
Bipartisan committee to probe Turing and its ilk about pricing practices
Source: $750/pill pharma company under investigation by Senate for price gouging | Ars Technica